BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

This publication has 15 references indexed in Scilit:

• Salvage Second Hematopoietic Cell Transplantation in Myeloma
  Transplantation and Cellular Therapy, 2013
• A Retrospective Analysis Comparing BEAM Versus Melphalan Prior to First Autologous Peripheral Blood Hematopoietic Stem Cell Transplant in Newly Diagnosed Multiple Myeloma Patients
  Blood, 2011
• Factors Influencing the Outcome of a Second Autologous Stem Cell Transplant (ASCT) in Relapsed Multiple Myeloma: A Study from the British Society of Blood and Marrow Transplantation Registry
  Transplantation and Cellular Therapy, 2011
• Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma
  Bone Marrow Transplantation, 2008
• International uniform response criteria for multiple myeloma
  Leukemia, 2006
• Standard Chemotherapy Compared With High-Dose Chemoradiotherapy for Multiple Myeloma: Final Results of Phase III US Intergroup Trial S9321
  Journal of Clinical Oncology, 2006
• Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma
  Cancer, 2006
• Clinical and biologic implications of recurrent genomic aberrations in myeloma
  Blood, 2003
• High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
  New England Journal of Medicine, 2003
• High-dose therapy autotransplantation/intensification vs continued standard chemotherapy in multiple myeloma in first remission. Results of a non-randomized study from a single institution
  Bone Marrow Transplantation, 2000